Skip to content

Effect of Tramadol in Prevention of Postpartum Depression

Effect of Tramadol in Prevention of Postpartum Depression

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03309163
Acronym
ETPPD
Enrollment
1230
Registered
2017-10-13
Start date
2017-10-09
Completion date
2019-08-13
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean Section

Brief summary

The incidence of postpartum depression in Europe and the United States is about 10%, while in China the incidence rate of 15.7-39.8%. Postpartum depression is one of the most common diseases of perinatal distress, but the current research of high-quality prevention and treatment of postpartum depression is still very lack. The study suggests that the risk of postpartum depression in cesarean delivery is significantly higher than that in vaginal delivery. Therefore, postpartum depression in cesarean delivery may require more attention and treatment.Tramadol is a non-opioid central analgesic that relieves common to severe pain, and tramadol has an inhibitory effect on norepinephrine and serotonin systems and has the potential to reduce depression and anxiety. Therefore, for the analgesic demand and antidepressant demand for maternal who undergoing cesarean section, tramadol may be an optimized and effective analgesic for the prevention and treatment of postpartum depression.

Detailed description

This study was designed according to a prospective, randomized, controlled clinical trial. Randomized subjects were randomly assigned to different analgesic drug-treated groups according to the random number induced by SPSS software. All three analgesic treatments were routinely used for clinical analgesia; Anesthesia, surgery, postoperative treatment are in accordance with clinical practice. The investigators conducted a postoperative questionnaire survey and psychological diagnosis for all patients. And blood sample was collected from patients before and 48 hours after the surgery.

Interventions

DRUGTramadol

Patient-controlled intravenous analgesia with Tramadol

DRUGHydromorphone

Patient-controlled intravenous analgesia with Hydromorphone

Patient-controlled epidural analgesia with Ropivacaine.

Sponsors

Xinqiao Hospital of Chongqing
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* 20 years old ≤ age ≤ 40 years old; * ASA score I-Ⅱ; * uncomplicated and singleton full-term pregnancy; * voluntarily to receive cesarean section and postoperative controlled analgesia; * consent to participate the study.

Exclusion criteria

* with history of mental disorders or psychotropic substances use; * with history of neurological diseases such as epilepsy * with history of previously known diagnosed depression; * with suicidal ideation or history of suicide; * with history of drug,alcohol or opioid abuse; * with monoamine oxidase (MAO) inhibitor treatment at present or in the past 14 days; * participating in other clinical studies * with severe heart disease, brain disease, liver disease and kidney disease; * be allergic to tramadol or opioids; * with any contraindication for combined spinal epidural anesthesia; * incapable of communication or cooperation.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of postpartum depressionAt 4 weeks after the surgeryDiagnosed according to DSM-5 diagnostic criteria for postnatal depression

Secondary

MeasureTime frameDescription
GAD-7 scoresAt 4 weeks and 3 months after the surgeryMeasured using Generalized Anxiety Disorder Scale
QoR-15 scores48 hours after the surgeryMeasured using Quality of recovery 15
Pain intensityAt 6, 12, 24 and 48 hours after the surgeryPain VAS at 6, 12, 24 and 48 hours after the surgery
Norepinephrine and serotonin levels in the bloodAt 48 hours after the surgeryNorepinephrine and serotonin concentration in the blood at 48 hours after the surgery
The incidence of postpartum depressionAt 3 months after the surgeryDiagnosed according to DSM-5 diagnostic criteria for postnatal depression
EPDS scoresAt 4 weeks and 3 months after the surgeryMeasured using Edinburgh Postnatal Depression Scale

Other

MeasureTime frameDescription
Pain intensityAt 3 months after the surgeryPostoperative pain intensity that evaluated by questionnaire at 3 months after the surgery
Early walking timeDuring hospitalization, an average of 36 hoursThe time for patient to independently activity
Hospital staysDuring hospitalization, an average of 72 hoursThe time for patient to stay in hospital after the surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026